2021
DOI: 10.1093/bioinformatics/btab847
|View full text |Cite
|
Sign up to set email alerts
|

Identifying cancer pathway dysregulations using differential causal effects

Abstract: Motivation Signaling pathways control cellular behavior. Dysregulated pathways, for example, due to mutations that cause genes and proteins to be expressed abnormally, can lead to diseases, such as cancer. Results We introduce a novel computational approach, called Differential Causal Effects (dce), which compares normal to cancerous cells using the statistical framework of causality. The method allows to detect individual ed… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 49 publications
0
7
0
Order By: Relevance
“…Systematic studies to investigate their differences would be worth pursuing. Furthermore, the idea of PRIDE may be applied in the study of differential causal effects (CE) recently proposed ( Tian et al 2016 , Wang et al 2018 , Jablonski et al 2022 ) to extend their approaches from testing CE to estimation of CE. In summary, the Bayesian approach to differential network analysis has opened up a promising research direction where the D-Net can be utilized in both association and classification studies.…”
Section: Discussionmentioning
confidence: 99%
“…Systematic studies to investigate their differences would be worth pursuing. Furthermore, the idea of PRIDE may be applied in the study of differential causal effects (CE) recently proposed ( Tian et al 2016 , Wang et al 2018 , Jablonski et al 2022 ) to extend their approaches from testing CE to estimation of CE. In summary, the Bayesian approach to differential network analysis has opened up a promising research direction where the D-Net can be utilized in both association and classification studies.…”
Section: Discussionmentioning
confidence: 99%
“…We then selected the genes that are differentially expressed between control and tumor samples, and expression data for the remaining genes (non-differentially expressed) are compressed in the principal components that preserve 99% of covariate information of the data [15]. From these principal components (PCs), only differentiated (differentially expressed) components are assumed as additional meta nodes in the network, representing the presence of potential covariates in the transition network, coming from the non-differentially expressed genes [14]. The conceptual idea for defining the differentially expressed principal components and for including them as additional variables in the presenting analysis is described in Section 2.1 and Figure 2B.…”
Section: Methodsmentioning
confidence: 99%
“…The expressions of the genes that were not selected as tumor genes (DE genes) might have such influence. To adjust for such effects on the transition mapping, we include meta nodes (adjustment variables in [14]) that represent the principal components of the expression data for these non-tumor genes (see Section 6). By the definition, principal components are vector representations of the general trends in a multi-dimensional data [15].…”
Section: A1 A2mentioning
confidence: 99%
“…The expressions of the genes that were not selected as tumor genes (DE genes) might have such influence. To adjust for such effects on the transition mapping, we include meta nodes (adjustment variables in [14]) that represent the principal components of the expression data for these non-tumor genes (see Section 'Materials and methods'). By the definition, principal components are vector representations of the general trends in a multidimensional data [15].…”
Section: Inference Of the Transition Networkmentioning
confidence: 99%